发明名称 DIAZABICYCLIC CENTRAL NERVOUS SYSTEM ACTIVE AGENT
摘要 <P>PROBLEM TO BE SOLVED: To provide a series of N-substituted diazabicyclic compound, a method for selectively controlling releasing of a synaptic transmission substance in mammals by using the compound, and a pharmaceutical composition including the compound. <P>SOLUTION: The present invention provides a compound expressed by formula (I), a pharmaceutical composition of the compound, and use of the composition to control synaptic transmission in mammals (in a nicotinic acetylcholine receptor ligand). In formula (I), A is selected from a group consisting of CH2, CH2CH2, and the like; B is selected from a group consisting of CH2 and CH2CH2, however, when A is CH2CH2CH2, B is CH2; Y is selected from a group consisting of CH2 and CH2CH2; Z is selected from a group consisting of CH2 and CH2CH2, however, when Y is CH2CH2, Z is a covalent bond, and when Z is CH2CH2, Y is a covalent bond; and Rl is pyridine or the like. <P>COPYRIGHT: (C)2012,JPO&INPIT
申请公布号 JP2012041349(A) 申请公布日期 2012.03.01
申请号 JP20110202172 申请日期 2011.09.15
申请人 ABBOTT LAB 发明人 SCHRIMPF MICHAEL R;TIETJE KARIN R;TOUPENCE RICHARD B;JI JIANGUO;BASHA ANWER;BUNNELLE WILLIAM H;DAANEN JEROME F;PACE JENNIFER M;SIPPY KEVIN B
分类号 C07D231/54;C07D487/04;A61K31/4439;A61K31/444;A61K31/454;A61K31/4545;A61P25/00;A61P25/04;A61P25/14;A61P25/16;A61P25/18;A61P25/24;A61P25/28;A61P25/34;C07D471/04 主分类号 C07D231/54
代理机构 代理人
主权项
地址